Feasibility of Ex Vivo Ligandomics is a research paper published in Biomolecules (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health (NIH)
Grant: R01EY036417
National Institutes of Health (NIH)
Grant: R01EY027749
National Institutes of Health (NIH)
Grant: R24EY028764
National Institutes of Health (NIH)
Grant: R43EY031238
National Institutes of Health (NIH)
Grant: R43EY032827
National Institutes of Health (NIH)
Grant: R21EY035421
National Institutes of Health (NIH)
Grant: R44EY027665
NEI NIH HHS
Grant: P30 EY002520
National Institutes of Health
Grant: 1R43EY031238-01
Anti-angiogenic gene therapy of ocular vascular diseases
National Institutes of Health
Grant: 5R44EY027665-03
Developing a novel therapy for diabetic retinopathy
National Institutes of Health
Grant: 1R01EY036417-01
Paradoxical role of anti-VEGF therapy in subretinal fibrosis of wet AMD
National Institutes of Health
Grant: 1R21EY035421-01
Developing a novel disease-targeted anti-angiogenic therapy for CNV
National Institutes of Health
Grant: 7R24EY028764-03
A selective angiogenesis blocker to treat retinopathy of prematurity
National Institutes of Health
Grant: 5P30EY002520-40
P30 - Core Grant for Vision Research
National Institutes of Health
Grant: 5R01EY027749-03
A Diabetic Retinopathy-Associated Vascular Permeability Factor
National Institutes of Health
Grant: 1R43EY032827-01
A new drug entity for combination therapy of diabetic retinopathy
FWCI
0.96
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords